These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12018777)

  • 1. Covariate-adjusted response-adaptive designs for binary response.
    Rosenberger WF; Vidyashankar AN; Agarwal DK
    J Biopharm Stat; 2001 Nov; 11(4):227-36. PubMed ID: 12018777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flexible design of two-stage adaptive procedures for phase III clinical trials.
    Koyama T
    Contemp Clin Trials; 2007 Jul; 28(4):500-13. PubMed ID: 17307399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covariate-adjusted adaptive designs for continuous responses in a phase III clinical trial: recommendation for practice.
    Biswas A; Huang HH; Huang WT
    J Biopharm Stat; 2006; 16(2):227-39. PubMed ID: 16584069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two new covariate adjustment methods for non-inferiority assessment of binary clinical trials data.
    Hou Y; Ding V; Li K; Zhou XH
    J Biopharm Stat; 2011 Jan; 21(1):77-93. PubMed ID: 21191856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An urn model for odds-ratio-based response-adaptive phase III clinical trials for two or more treatments.
    Basak GK; Biswas A; Volkov S
    J Biopharm Stat; 2009 Sep; 19(5):838-56. PubMed ID: 20183447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive designs for confirmatory clinical trials.
    Bretz F; Koenig F; Brannath W; Glimm E; Posch M
    Stat Med; 2009 Apr; 28(8):1181-217. PubMed ID: 19206095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample size determination for comparing several survival curves with unequal allocations.
    Halabi S; Singh B
    Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A group sequential adaptive treatment assignment design for proof of concept and dose selection in headache trials.
    Hall DB; Meier U; Diener HC
    Contemp Clin Trials; 2005 Jun; 26(3):349-64. PubMed ID: 15911469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A class of Covariate-Adjusted Response-Adaptive Allocation Designs for Multitreatment Binary Response Trials.
    Biswas A; Bhattacharya R
    J Biopharm Stat; 2018; 28(5):809-823. PubMed ID: 29913107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive biased-coin designs for skewing the allocation proportion in clinical trials with normal responses.
    Atkinson AC; Biswas A
    Stat Med; 2005 Aug; 24(16):2477-92. PubMed ID: 16007571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two stage conditional power adaptive design adjusting for treatment by covariate interaction.
    Ayanlowo AO; Redden DT
    Contemp Clin Trials; 2008 May; 29(3):428-38. PubMed ID: 18053774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential urn designs with elimination for comparing K > or =3 treatments.
    Coad DS; Ivanova A
    Stat Med; 2005 Jul; 24(13):1995-2009. PubMed ID: 15803441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian adaptive biased-coin designs for clinical trials with normal responses.
    Atkinson AC; Biswas A
    Biometrics; 2005 Mar; 61(1):118-25. PubMed ID: 15737084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating adjusted NNTs in randomised controlled trials with binary outcomes: a simulation study.
    Bender R; Vervölgyi V
    Contemp Clin Trials; 2010 Sep; 31(5):498-505. PubMed ID: 20624484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
    Morgan CC; Stephen Coad D
    Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of omitted covariates on confidence interval and study power in binary outcome analysis: a simulation study.
    Negassa A; Hanley JA
    Contemp Clin Trials; 2007 May; 28(3):242-8. PubMed ID: 17011835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covariate-adjusted response-adaptive designs for longitudinal treatment responses: PEMF trial revisited.
    Biswas A; Park E; Bhattacharya R
    Stat Methods Med Res; 2012 Aug; 21(4):379-92. PubMed ID: 20974667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing treatment effects in unconfounded studies under model misspecification: logistic regression, discretization, and their combination.
    Cangul MZ; Chretien YR; Gutman R; Rubin DB
    Stat Med; 2009 Sep; 28(20):2531-51. PubMed ID: 19572258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seamless Phase II/III combination study through response adaptive randomization.
    Wang L; Cui L
    J Biopharm Stat; 2007; 17(6):1177-87. PubMed ID: 18027224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive design and estimation in randomized clinical trials with correlated observations.
    Yin G; Shen Y
    Biometrics; 2005 Jun; 61(2):362-9. PubMed ID: 16011682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.